Neurocrine Biosciences reported $205.1M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 173.33M 14.84M
Acorda Therapeutics ACOR:US $ 57.64M 58.91M
Adamas Pharmaceuticals ADMS:US 28.84M 7.15M
Agios Pharmaceuticals AGIO:US $ 91.22M 45.26M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 363.82M 6.04M
Amgen AMGN:US $ 3.77B 854M
Aptinyx Inc APTX:US $ 15.29M 3.73M
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Cytokinetics CYTK:US $ 47.16M 4.03M
Dynavax Technologies DVAX:US $ 54.81M 23.36M
Enanta Pharmaceuticals ENTA:US $ 49.83M 5.79M
Exelixis EXEL:US $ 274.84M 29.08M
Gilead Sciences GILD:US $ 3533M 1237M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Halozyme Therapeutics HALO:US $ 59.25M 15.17M
Intercept Pharmaceuticals ICPT:US $ 111.01M 12.86M
Intra Cellular Therapies ITCI:US $ 69.1M 4.69M
Nektar Therapeutics NKTR:US $ 133.04M 1.14M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Pfizer PFE:US $ 13063M 3998M
Prothena PRTA:US 32.27M 1.6M
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Repligen RGEN:US $ 114.72M 8.27M
Rigel Pharmaceuticals RIGL:US $ 39.26M 1.99M
Sarepta Therapeutics SRPT:US $ 298.8M 17.06M
Teva Pharmaceutical TEVA:IT 3.33B 220M
Ultragenyx Pharmaceutical RARE:US $ 205.96M 18.34M
Vertex Pharmaceuticals VRTX:US $ 836.48M 45.55M
Xoma XOMA:US $ 6.8M 3.09M
YTE INCY:US $ 505.92M 119.36M
Zogenix ZGNX:US $ 65.49M 10.79M